Localized Warm Gas Therapy Device for Dermatological Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medical gas therapies, such as Hyperbaric Oxygen Therapy, are costly, cause discomfort, and have side effects like pressure-related trauma, and are not suitable for localized treatment of dermatological and sub-cutaneous tissue conditions, particularly for conditions like diabetic foot ulcers and burns, due to their non-targeted delivery of gases.

Innovation Solution

A device for localized delivery of warm therapeutic gases, using a gas warmer assembly and microprocessor-controlled heaters to maintain precise temperature in treatment chambers, allowing targeted treatment with reduced gas consumption and enhanced bioactive agent absorption, which can be used for conditions like diabetic foot ulcers, burns, and nail afflictions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If Hyperbaric Oxygen Therapy is used to treat dermatological and sub-cutaneous tissue conditions, then therapeutic gas delivery is achieved, but the treatment is costly and causes discomfort with side effects like pressure-related trauma

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidpressure-related trauma and discomfort
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by transitioning from systemic hyperbaric oxygen therapy to localized delivery of therapeutic gases directly to the treatment area. The device uses a delivery probe positioned near or on the affected tissue, enabling targeted gas administration without subjecting the entire body to high pressure, thus eliminating pressure-related trauma while maintaining therapeutic effectiveness for dermatological and sub-cutaneous conditions

Inventive Principle:
Principle #3Local quality

2Reliability

If Hyperbaric Oxygen Therapy is used for treatment, then therapeutic gas is delivered to the patient, but the delivery is not localized and treats the entire body rather than specific conditions

Engineering Contradiction:
Improvetherapeutic gas deliveryVSAvoidlocalized treatment capability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies segmentation by dividing the therapeutic gas delivery system into localized components. Instead of treating the entire body, the device segments the treatment to specific dermatological and sub-cutaneous areas using a delivery probe that can be positioned at the target site. This enables adaptable, condition-specific treatment while maintaining reliable therapeutic gas delivery

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by transitioning from systemic hyperbaric oxygen therapy to localized delivery of therapeutic gases directly to the treatment area. The device uses a delivery probe positioned near or on the affected tissue, enabling targeted gas administration without subjecting the entire body to high pressure, thus eliminating pressure-related trauma while maintaining therapeutic effectiveness for dermatological and sub-cutaneous conditions

Inventive Principle:
Principle #3Local quality

3Reliability

If conventional gas therapy is used, then treatment is provided, but gas consumption is high and treatment efficiency is reduced

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidgas consumption
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent applies local quality by transitioning from systemic hyperbaric oxygen therapy to localized delivery of therapeutic gases directly to the treatment area. The device uses a delivery probe positioned near or on the affected tissue, enabling targeted gas administration without subjecting the entire body to high pressure, thus eliminating pressure-related trauma while maintaining therapeutic effectiveness for dermatological and sub-cutaneous conditions

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent applies the extraction principle by isolating the therapeutic gas delivery to only the areas requiring treatment, rather than delivering gas systemically throughout the body. This targeted approach extracts the essential therapeutic function from the conventional method and delivers it efficiently to the specific site, reducing overall gas consumption while maintaining treatment effectiveness

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device provides efficient, comfortable, and cost-effective localized treatment by increasing blood supply, reducing infection, and enhancing healing through precise gas delivery and bioactive agent absorption, making it suitable for various dermatological and sub-cutaneous tissue conditions.

Implementation Method 1

a gas warmer assembly to warm a first gas to a temperature in a first temperature range to obtain warm first gas

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 2

The first portion substantially passes through the first delivery unit. The warm first gas warms the therapeutic gas in the first portion to obtain warm therapeutic gas

Methodology Applied
Scientific EffectThermal convection: Convection

Data Source

PatentUS20240277513A1Devices and methods for warm gas therapy
Publication Date: 2024.08.22 YOSTRA LABS PVT LTD
  • US20240277513A1 patent drawing
  • US20240277513A1 patent drawing
  • US20240277513A1 patent drawing

AI summary

Devices and method for warm gas therapy is provided. Device comprises a gas warmer assembly to warm a first gas to a temperature in a first temperature range to obtain warm first gas. The device comprises a first delivery unit that can deliver the warm first gas to a main treatment chamber which encloses a sub-treatment chamber to retain heat therein. A second delivery unit can receive a therapeutic gas from a gas supply. The second delivery unit comprises a first portion and a second portion. The first portion substantially passes through the first delivery unit and therapeutic gas in the first portion is warmed by the warm first gas. The second portion delivers the warm therapeutic gas to a sub-treatment chamber. The sub-treatment chamber encloses a body part of a patient.